Lisa M. Smith

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with <i>In vitro</i> and <i>In vivo</i> Antitumor Activity

Christine M. Chresta, Barry R. Davies, Ian Hickson et al. · Cancer Research · 2009 · 790 citations · Full text

Mtorc2 Substrate Akt, Cell Death, Pharmacotherapy +21

Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts

Vibha N. Lama, Lisa M. Smith, Linda Badri et al. · Journal of Clinical Investigation · 2007 · 323 citations · Full text

Differential effects of 5-hydroxytryptamine1A selective drugs on the 5-HT behavioral syndrome

Lisa M. Smith, Stephen J. Peroutka · Pharmacology Biochemistry and Behavior · 1986 · 245 citations

Differential Effects, Psychoactive Drug, Psychiatry +15

The Novel Poly(ADP-Ribose) Polymerase Inhibitor, AG14361, Sensitizes Cells to Topoisomerase I Poisons by Increasing the Persistence of DNA Strand Breaks

Lisa M. Smith, Elaine Willmore, Caroline A. Austin et al. · Clinical Cancer Research · 2005 · 125 citations

Apoptosis, Cell Death, Molecular Biology +17

Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity

Nattawadee Panyain, Aurélien Godinat, Thomas Lanyon‐Hogg et al. · Journal of the American Chemical Society · 2020 · 107 citations · Full text

Drug Target, Selective Uchl1 Probe, Chemical Biology +25